Use of Anti-Dementia Drugs Reduces the Risk of Potentially Inappropriate Medications: A Secondary Analysis of a Nationwide Survey of Prescribing Pharmacies.


Journal

Dementia and geriatric cognitive disorders
ISSN: 1421-9824
Titre abrégé: Dement Geriatr Cogn Disord
Pays: Switzerland
ID NLM: 9705200

Informations de publication

Date de publication:
2020
Historique:
received: 05 09 2020
accepted: 30 09 2020
pubmed: 7 12 2020
medline: 16 6 2021
entrez: 6 12 2020
Statut: ppublish

Résumé

As the number of older people with dementia increases, safe pharmacotherapy in this population has attracted attention in recent years. The aims of this study were to clarify the prescribing patterns in older patients who were prescribed anti-dementia drugs and to investigate the association of potentially inappropriate medications (PIMs) with the use of anti-dementia drugs. Adults aged ≥65 years, who were prescribed anti-dementia drugs at 585 pharmacies across Japan (N = 7,953), were surveyed. The percentage of prescriptions of anti-dementia drugs and the effect of those prescriptions on PIMs were investigated. Prescriptions of anti-dementia drugs were found in 4.4% of the entire study population. A multiple logistic regression analysis revealed that the use of anti-dementia drugs reduced the risk of prescribing psychotropic drugs, which represented PIMs, and that a combination of anti-dementia drugs (e.g., cholineesterase inhibitor with memantine) may reduce the risk of prescribing PIMs compared with monotherapy. The use of anti-dementia drugs was associated with fewer prescriptions of drugs considered as PIMs.

Identifiants

pubmed: 33279893
pii: 000512043
doi: 10.1159/000512043
pmc: PMC7949214
doi:

Substances chimiques

Nootropic Agents 0
Psychotropic Drugs 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

526-532

Informations de copyright

The Author(s). Published by S. Karger AG, Basel.

Références

Aging Ment Health. 2011 Nov;15(8):978-84
pubmed: 21777080
BMJ Open. 2013 Jan 07;3(1):
pubmed: 23299113
BMJ Open. 2020 Jan 2;10(1):e029172
pubmed: 31900263
CNS Neurosci Ther. 2016 Mar;22(3):159-66
pubmed: 26778658
Ann Intern Med. 2018 Jan 2;168(1):52-62
pubmed: 29255909
Diabet Med. 2018 Jul;35(7):838-845
pubmed: 29633351
Am J Geriatr Psychiatry. 2019 Feb;27(2):181-185
pubmed: 30503701
Neurobiol Aging. 2000 Mar-Apr;21(2):171-81
pubmed: 10867202
J Alzheimers Dis. 2016 Nov 19;55(2):691-701
pubmed: 27716668
Dement Geriatr Cogn Disord. 2013;35(5-6):239-48
pubmed: 23485654
Ann Intern Med. 2007 Jun 5;146(11):775-86
pubmed: 17548409
PLoS One. 2017 Apr 12;12(4):e0175475
pubmed: 28403222
J Am Med Dir Assoc. 2012 Oct;13(8):759.e7-13
pubmed: 22727993
J Am Med Dir Assoc. 2018 Nov;19(11):959-966.e4
pubmed: 30262440
J Gerontol A Biol Sci Med Sci. 2010 Mar;65(3):318-21
pubmed: 19843646
J Clin Pharmacol. 2009 Oct;49(10):1176-84
pubmed: 19783711
J Am Geriatr Soc. 2009 Jun;57(6):1007-14
pubmed: 19467144
Geriatr Gerontol Int. 2016 Sep;16(9):983-1001
pubmed: 27594406
Int Psychogeriatr. 2008 Aug;20(4):800-6
pubmed: 18341753
Int J Geriatr Psychiatry. 2018 May 20;:
pubmed: 29781202
Drugs Aging. 2014 Oct;31(10):769-76
pubmed: 25200414
J Am Coll Cardiol. 2018 Jun 5;71(22):2570-2584
pubmed: 29852980
Am J Geriatr Pharmacother. 2009 Oct;7(5):271-80
pubmed: 19948303
Int J Clin Pharmacol Ther. 2008 Feb;46(2):72-83
pubmed: 18218287
Am J Geriatr Pharmacother. 2009 Apr;7(2):74-83
pubmed: 19447360
JAMA. 2009 Apr 15;301(15):1565-72
pubmed: 19366776
Arch Gerontol Geriatr. 2018 Jul - Aug;77:8-12
pubmed: 29587175
Nat Rev Neurol. 2014 Apr;10(4):184-6
pubmed: 24638134
J Gerontol A Biol Sci Med Sci. 2014 Oct;69(10):1299-305
pubmed: 24899525
BMC Psychiatry. 2014 Mar 20;14:84
pubmed: 24645776

Auteurs

Yusuke Suzuki (Y)

Center for Community Liaison and Patient Consultations, Nagoya University Hospital, Nagoya, Japan, yus@med.nagoya-u.ac.jp.

Mikio Sakakibara (M)

Sugi Pharmacy Co., Ltd., Obu, Japan.

Nariaki Shiraishi (N)

Department of Rehabilitation, Faculty of Health Sciences, Nihon Fukushi University, Nihon, Japan.

Hitoshi Komiya (H)

Center for Community Liaison and Patient Consultations, Nagoya University Hospital, Nagoya, Japan.

Masahiro Akishita (M)

Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Masafumi Kuzuya (M)

Department of Community Healthcare and Geriatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH